1186-1197 of 1197
Adjustment to Diabetes Diagnosis / New Technology
Clinician's RoundtableAdjustment to Diabetes Diagnosis / New Technology
Lori Laffel, MD, MPH
Cathleen Margolin, PhD
Trends in the Treatment of Type 1 diabetes
Clinician's RoundtableTrends in the Treatment of Type 1 diabetes
Lori Laffel, MD, MPH
Cathleen Margolin, PhD
Lori Laffel, MD, MPH
Cathleen Margolin, PhD
Controversies in Hormonal Supplementation Regimes
Clinician's RoundtableControversies in Hormonal Supplementation Regimes
Alan Mintz, MD
Maurice Pickard, MD
Conception and Design of the Cenegenics Institute
Clinician's RoundtableConception and Design of the Cenegenics Institute
Alan Mintz, MD
Maurice Pickard, MD
Identification and Management of Type 1 Diabetes
Clinician's RoundtableIdentification and Management of Type 1 Diabetes
Lori Laffel, MD, MPH
Cathleen Margolin, PhD
- advertisement
New Drug for Diabetic Patients in Phase 2 Trials
Clinician's RoundtableNew Drug for Diabetic Patients in Phase 2 Trials
Noah Berkowitz, MD
Shira Johnson, MD
New Drug for Cardiovascular Complications-Diabetes
Clinician's RoundtableNew Drug for Cardiovascular Complications-Diabetes
Shira Johnson, MD
Noah Berkowitz, MD
A Continuation of the AMA's Policy Reform Efforts
Clinician's RoundtableA Continuation of the AMA's Policy Reform Efforts
Rebecca Patchin, MD
Steven Marquardt, MD
Joel Heller, MD
Steven DeAngeles, MD
Steven DeAngeles, MD
Joel Heller, MD
Building A Common Vision In The Hospital Setting
Clinician's RoundtableBuilding A Common Vision In The Hospital Setting
Dennis Millirons, MHA
Mark Nolan Hill, MD
- advertisement